| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.04 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |